The study protocol was approved by the Institutional Review Board and informed consent was obtained according to the declaration of Helsinki. Each subject made two visits to the research laboratory. At the first visit, screening assessments were performed to ensure that subjects met the inclusion–exclusion criteria, and that they formed a relatively uniform sample to facilitate interpretation of their descriptions that were not affected by other perceptual, cognitive and/or language deficits or comorbid conditions.